• Publications
  • Influence
A nationwide survey of hypertrophic pachymeningitis in Japan
Objectives To clarify the prevalence, frequent causes and distinct features of hypertrophic pachymeningitis (HP) according to background conditions in a nationwide survey in Japan. Methods The studyExpand
  • 84
  • 15
  • PDF
Anti-neurofascin antibody in patients with combined central and peripheral demyelination
Objectives: We aimed to identify the target antigens for combined central and peripheral demyelination (CCPD). Methods: We screened target antigens by immunohistochemistry and immunoblotting usingExpand
  • 114
  • 14
Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy
To investigate anti‐neurofascin 155 (NF155) antibody‐positive chronic inflammatory demyelinating polyneuropathy (CIDP).
  • 93
  • 9
  • PDF
Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
Background Differences in cytokine/chemokine profiles among patients with neuromyelitis optica (NMO), relapsing remitting multiple sclerosis (RRMS), and primary progressive MS (PPMS), and theExpand
  • 127
  • 8
  • PDF
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Opticospinal multiple sclerosis (OSMS) in Asians has similar features to the relapsing-remitting form of neuromyelitis optica (NMO) seen in Westerners. OSMS is suggested to be NMO based on theExpand
  • 255
  • 7
  • PDF
Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis
The arachidonic acid (AA) cascade produces eicosanoids, such as prostaglandins (PGs), that regulate physiological and pathological functions. Although various nonsteroidal anti-inflammatory drugsExpand
  • 110
  • 7
  • PDF
A nationwide survey of combined central and peripheral demyelination in Japan
Objectives To clarify the clinical features of combined central and peripheral demyelination (CCPD) via a nationwide survey. Methods The following characteristics were used to define CCPD: T2Expand
  • 38
  • 7
Connexin 43 Astrocytopathy Linked to Rapidly Progressive Multiple Sclerosis and Neuromyelitis Optica
Background Multiple sclerosis (MS) and neuromyelitis optica (NMO) occasionally have an extremely aggressive and debilitating disease course; however, its molecular basis is unknown. This study aimedExpand
  • 66
  • 7
  • PDF
CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis
We measured the levels of 27 cytokines/chemokines and growth factors in cerebrospinal fluid (CSF) from 42 patients with sporadic amyotrophic lateral sclerosis (ALS), 12 patients with lower motorExpand
  • 76
  • 6
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis
Background: We reported the emergence of a distinct myelitis in patients with atopic diathesis (atopic myelitis [AM]) by a nationwide survey throughout Japan. Similar cases have recently beenExpand
  • 74
  • 5